| Name | Title | Contact Details |
|---|---|---|
Keith Moore |
Vice President Research And Development | Profile |
Beth Hamilton |
Vice President, Generic Product Sales | Profile |
Brant Schofield |
Executive Vice President Specialty Products Division | Profile |
Daniel Moore |
Executive Vice President, Generic Products Division | Profile |
Metabolic Solutions Development Company, LLC (MSDC) discovers and develops novel molecular targets and new therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company has raised nearly $55 million in support of the development of its novel therapeutic drugs, MSDC-0160 and MSDC-0602, which selectively modulate mitochondrial control of to important cellular activities, such as carbohydrate, lipid, and amino acid metabolism, that are out of balance in patients with type 2 diabetes. Such imbalances may also play a role in other diseases of aging such as Alzheimer’s disease and Parkinson’s disease, as well certain genetic diseases such as polycystic kidney disease.
Sss Co is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Headcan is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Leading Pharma, LLC is a privately owned generic pharmaceutical company that purchases, licenses, develops, manufactures and distributes high-quality, safe and effective products to drugstore chains, distributors, wholesalers, mass merchandisers, government agencies and managed care accounts in the U.S. Our products are available in various dosage forms across many therapeutic areas under the Leading label.